跳至主要内容
临床试验/CTRI/2022/09/045143
CTRI/2022/09/045143尚未招募未知

Comparative Evaluation of a Herbal Formulation and Amlodipine in Essential hypertension

GURUKUL CAMPUS UAU HARDWAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients willing to participate in the study.
  • 2)Patients of either sex with age between 18-70 years.
  • 3)Patients having Hypertension between time interval of 6 months to 1 year.
  • 4)Patients suffering from stage 1 Hypertension (SBP140-159mmHg, DBP 90-99mmHg)
  • 5)Patients suffering from Isolated Systolic Hypertension.

排除标准

  • 1)Patients not willing to participate in the study.
  • 2)Patients of either sex below 18 years & above 70 years will be excluded from the study.
  • 3)Patients having Hypertension for <6 months and >1 year will be excluded.
  • 4)Patients of stage 2 Hypertension (SBP >160mmHg and DBP >100mmHg)
  • 5)Patients suffering from serious comorbidities like Renal failure, Coronary Artery Disease, taking medication/drug (oral contraceptives, steroids, chronic use of NSAIDs etcââ?¬Â¦)
  • 6)Alcoholic and/or drug abusers.
  • 7)History of hypersensitivity to the trail drugs or any of its ingredients.
  • 8)Pregnant /lactating woman.
  • 9)Patients who have completed participation in any other clinical trail during the past 6 months.

研究者

发起方
GURUKUL CAMPUS UAU HARDWAR

相似试验